Page Banner
Mayo Clinic Laboratories > BioPharma Diagnostics > Testing > Infectious diseases

INFECTIOUS DISEASES

A WEALTH OF TESTING EXPERIENCE

BioPharma Diagnostics offers access to the infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the bacterial, viral, fungal, and parasitic agents of infectious diseases.

Performing more than four million tests annually, our seven clinical microbiology laboratories have developed and implemented in vitro and culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization of microbial pathogens.

Our laboratories are managed by physician-scientists, many of whom are actively engaged in clinical practice and research. Through BioPharma Diagnostics, our partners have access to a wealth of world-renowned expertise to help guide test ordering and interpret results.

To learn more about our testing, view our biopharma-specific test catalog and full test catalog.

Test menu

Full suite of infectious disease testing Full suite of infectious disease testing
Full suite of infectious disease testing

Our internationally renowned clinical microbiology laboratories offer a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases. We have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.

Fungal infections Fungal infections
Fungal infections

Our comprehensive fungal infection testing menu is supported by ongoing innovation and development of novel testing methods and strategies and enable detection of a wide range of clinically significant pathogens, including newly emerging species.

Helicobacter pylori Helicobacter pylori
Helicobacter pylori

Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.

Infectious disease pathology Infectious disease pathology
Infectious disease pathology

Our practice provides regular exposure, not only to the common infections, but also to uncommon infections that most pathologists may only see once in their careers.

Vector-borne diseases Vector-borne diseases
Vector-borne diseases

Our internationally renowned clinical microbiology laboratories span all areas of conventional, molecular, and serological medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the pathogens associated with infectious diseases.

Comprehensive disease testing

Through BioPharma Diagnostics, our partners have access to Mayo Clinic Laboratories’ infectious disease test catalog, including testing for:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Helicobacter pylori
  • Infectious disease pathology
  • Vector-borne diseases
  • HIV and hepatitis

Our molecular testing methods include:

  • Polymerase chain reaction (PCR) testing
  • Advanced whole genome microbial sequencing
  • Targeted metagenomic sequencing
  • Matrix-assisted laser-desorption/ionization-time of flight (MALDI-TOF) mass spectrometry organism identification

In addition to using clinically available testing, BioPharma Diagnostics partners can access infectious disease testing for clinical trials and be among the first to use up-and-coming tests currently in development.

News and updates

The latest

Close-up of a microscope lens focused on a slide.
Dr. Morice discusses lab market trends with the Advisory Board

William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.

Learn more
Should You Worry if You Accidentally Swallow an Insect?

During summer activities, it's bound to happen. But how dangerous is it to accidentally swallow a bug? Bobbi Pritt, M.D., a microbiologist, pathologist, and Director of the Clinical Parasitology Laboratory at Mayo Clinic in Rochester, discusses when swallowing an insect is harmless and which ones can be dangerous in The Wall Street Journal column entitled, "Burning Question."

INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.